MFT Research finds cellular immunity to virus that causes COVID-19
Cellular (T-cell) immunity against SARS-CoV-2 is likely to be present within most adults for at least six months after infection, according to research carried out at MFT.
Read moreResearch and innovation news
Keep up-to-date with the latest news, publications and events from the Research and Innovation team at MFT.
Manchester research leads to NICE recommendation for Lynch syndrome screening for womb cancer patients
Women diagnosed with womb cancer should now be routinely screened for the genetic condition Lynch syndrome (LS), following a new guideline issued by the National Institute for Health and Care Excellen
Read more
Wythenshawe patient takes part in national project to understand changes to radiotherapy treatments during COVID-19
A lung cancer patient at Wythenshawe Hospital has taken part in a national project led by Manchester researchers, investigating changes in radiotherapy treatments during COVID-19.
Read more
MFT lupus patient first recruit to NIHR IMID BioResource
A lupus patient at the Manchester Royal Infirmary (MRI) was the first UK recruit to the newly launched NIHR IMID BioResource.
Read more
Protein by which common skin bacteria trigger eczema identified
A decade-long study has identified the factor produced by a common species of skin bacteria that triggers eczema.
Read more
MFT cancer professor receives honour from Royal College of Obstetricians and Gynaecologists
Read more
Drug has potential to improve cardiovascular health in preeclamptic women – MFT research shows
A drug has shown potential to improve heart function in women diagnosed with preeclampsia during their pregnancy, research carried out at Saint Mary’s Hospital has found.
Read more
MFT team recruits first UK patient to ‘OSCAR’ COVID-19 research study
The first UK patient has been treated in new COVID-19 research trialling the impact of an experimental arthritis drug, otilimab, on severe lung disease related to COVID-19.
Read more
